Sanofi Consumer Healthcare India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sanofi Consumer Healthcare India has informed the stock exchanges that its trading window will remain closed from 1st October 2025 until 48 hours after the announcement of its Unaudited Standalone Financial Results for the quarter and nine months ended 30th September 2025. This is a routine compliance measure under SEBI's Prohibition of Insider Trading Regulations, 2015, and the company's own insider trading code. During this period, designated persons are restricted from trading in the company's shares. The filing was signed by Nikunjkumar Savaliya, Company Secretary and Compliance Officer.
This is a standard regulatory filing and not a material business event. It signals that the company is preparing to announce its Q2 FY26 results soon, but carries no direct impact on the stock price or shareholder value.